4.6 Review

Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets

Journal

TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 31, Issue 12, Pages 939-951

Publisher

CELL PRESS
DOI: 10.1016/j.tem.2020.10.004

Keywords

-

Funding

  1. French Ministry of Research
  2. Regional Council of Bourgogne Franche-Comte, FEDER
  3. Association de Cardiologie de Bourgogne

Ask authors/readers for more resources

Growth and differentiation factor 15 (GDF15) belongs to the transforming growth factor-beta (TGF-beta) superfamily proteins. GDF15 acts as an inflammatory marker, and it plays a role in pathogenesis of tumors, ischemic diseases, metabolic disorders, and neurodegenerative processes. GDF15 is not normally expressed in the tissue; it is prominently induced following 'injury'. GDF15 functions are critical for the regulation of endothelial adaptations after vascular damage. Recently, four research groups simultaneously identified glial-derived neurotrophic factor (GDNF)-family receptor a-like (GFRAL) in the brain, an orphan receptor as the receptor for GDF15, signaling through the coreceptor RET. In this article, new aspects of the biology of GDF15 and receptor GFRAL, and their relationship with various pathologies, are commented on.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available